Phase I trial of vinflunine and pemetrexed in refractory solid tumors

BACKGROUND: Vinflunine is a novel vinca alkaloid with promising single agent clinical activity. Pemetrexed has at least additive activity with other vincas. A phase I trial was undertaken to assess the safety of vinflunine and pemetrexed in patients with refractory solid tumors. METHODS: A standard...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Sanoff, Hanna K., Davies, Janine, Walko, Christine, Buie, Larry, Chiu, Wing-Keung, Ivanova, Anastasia, O’Neil, Bert, Stinchcombe, Thomas E., Keller, Kimberly, Dees, E. Claire
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2009
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3143820/
https://ncbi.nlm.nih.gov/pubmed/19830387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-009-9344-3
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk